For citations:
Kalach S.E., Denisenko A.S., Riss M.E., Shchelochkova I.V., Isakov V.E., Stepin I.A., Cheptsov G.R. Experience with the use of monoclonal antibodies, interleukin-6 inhibitors, in patients with a new coronavirus infection of medium degree of severity. Title in english. 2022;(2(127)):103-106. (In Russ.) https://doi.org/10.34680/2076-8052.2022.2(127).103-106
Email this article 